Skip to main content
. 2020 Nov 26;10(1):23–33. doi: 10.1002/cam4.3593

Figure 3.

Figure 3

Graft‐versus‐host disease‐free, relapse‐free survival in patients with KPS score <80% receiving MAC or RIC regimen